The effect of oral supplementation of Paricalcitol on C-reactive protein levels in chronic kidney disease patients: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials

Seyyed Mostafa Arabi (Creator)
Mostafa Shahraki-Jazinaki (Creator)
Mahla Chambari (Creator)
Leila Sadat Bahrami (Creator)
Sara Sabeti (Creator)
Mohammaed Ibrahim Mohaildeen Gubari (Creator)
Basil Roufogalis (Creator)
Amirhossein Sahebkar (Creator)

Dataset

1 Article

1 results

2024
The effect of oral supplementation of paricalcitol on C-reactive protein levels in chronic kidney disease patients : GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials
Arabi, S. M., Shahraki-Jazinaki, M., Chambari, M., Bahrami, L. S., Sabeti, S., Gubari, M. I. M., Roufogalis, B. D. & Sahebkar, A., Dec 2024, In: BMC Pharmacology and Toxicology. 25, 1, 9 p., 19.
Research output: Contribution to journal › Article › peer-review

Open Access
3 Citations (Scopus)